During the past decade, HIPPOKRATION General Hospital of Athens conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 13 clinical trials were completed, i.e. on average, 41.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 10 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HIPPOKRATION General Hospital of Athens" #1 sponsor was "Shire" with 6 trials, followed by "Bayer" with 4 trials sponsored, "Medtronic Vascular" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "University of Minnesota" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HIPPOKRATION General Hospital of Athens" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "251 General Airforce Hospital" with 1 trials as a collaborator, "401 General Military Hospital of Athens" with 1 trials as a collaborator and "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "HIPPOKRATION General Hospital of Athens" are "Hypertension" (5 trials), "Cardiovascular Diseases" (4 trials), "Crohn's Disease" (4 trials), "Hepatitis B" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "HIPPOKRATION General Hospital of Athens" in a lesser frequency.

Most popular intervention types in "HIPPOKRATION General Hospital of Athens" are "Drug" (28 trials), "Device" (7 trials), "Other" (5 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Ontamalimab" (4 trials), "Guselkumab" (3 trials), "Adefovir" (2 trials) and "Clevudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "HIPPOKRATION General Hospital of Athens" are 44 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 23 active trials in "HIPPOKRATION General Hospital of Athens". 1 are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in HIPPOKRATION General Hospital of Athens, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in HIPPOKRATION General Hospital of Athens, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".